Clinical Trial Update: A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing three regimens (high-dose lenalidomide; lenalidomide plus azacitidine; azacitidine) in adults ≥65 with newly diagnosed acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Acute Myeloid Leukemia, Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-07-04